Medicare Enrolled

Dr. Sergio Waxman, M.D.

Cardiovascular Disease · Burlington, MA
Practice pattern: Interventional & Cardiac — Practice combining interventional and cardiac services
Consulting-driven
41 MALL RD, Burlington, MA 01805
7817448254
In practice since 2006 (20 years)
NPI: 1720003494 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Waxman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waxman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Waxman

Dr. Sergio Waxman is a cardiovascular disease specialist in Burlington, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Waxman performed 32 Medicare services across 29 unique beneficiaries.

Between the years covered by Open Payments, Dr. Waxman received a total of $156,393 from 40 pharmaceutical and/or device companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Waxman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 32 Medicare services $156,393 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32
Medicare services
Bottom 2% in MA for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
29
Unique beneficiaries
$342
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Transcatheter aortic valve replacement via femoral artery
A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery.
16 $631 $4,781
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $52 $594
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.0% high complexity
0.0% medium
50.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$156,393
Total received (2018-2024)
Avg $22,342/year across 7 years
Top 4% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
444
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$120,585 (77.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,438 (17.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,370 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,921
2023
$19,199
2022
$12,414
2021
$27,985
2020
$24,706
2019
$40,459
2018
$23,709

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,000
Edwards Lifesciences Corporation
$2,856
Boston Scientific Corporation
$357
ZOLL Circulation Inc
$151
ShockWave Medical, Inc
$149
ABIOMED
$116
Inari Medical, Inc.
$104
Medtronic, Inc.
$82
PFIZER INC.
$51
Philips North America LLC
$40
Novartis Pharmaceuticals Corporation
$16
Top 3 companies account for 91.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$42,456
BOSTON SCIENTIFIC CORPORATION
$31,346
BioCardia, Inc.
$13,200
Medtronic, Inc.
$11,531
Procyrion, Inc.
$9,712
Abbott Laboratories
$8,858
Surmodics, Inc.
$7,400
Edwards Lifesciences Corporation
$6,312
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6,189
W. L. Gore & Associates, Inc.
$5,360
Medtronic Vascular, Inc.
$3,454
Cardiovascular Systems Inc.
$1,670
ZOLL Circulation Inc
$1,621
Siemens Medical Solutions USA, Inc.
$1,418
Corindus Inc.
$1,275
HeartFlow, Inc.
$1,100
Philips Electronics North America Corporation
$1,001
Bard Peripheral Vascular, Inc.
$345
ABIOMED
$321
ShockWave Medical, Inc
$259
Novartis Pharmaceuticals Corporation
$184
CARDIVA MEDICAL, INC.
$177
iRhythm Technologies, Inc.
$159
CORDIS US CORP.
$135
CVRx, Inc.
$130
Endologix LLC
$112
Inari Medical, Inc.
$104
PFIZER INC.
$98
Amgen Inc.
$86
EKOS Corporation
$62
E.R. Squibb & Sons, L.L.C.
$52
Actelion Pharmaceuticals US, Inc.
$49
Philips North America LLC
$40
LimFlow Inc.
$40
Haemonetics Corporation
$36
Janssen Pharmaceuticals, Inc
$31
Acist Medical Systems, Inc.
$21
Cagent Vascular INC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Amarin Pharma Inc.
$15
Top 3 companies account for 55.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (9520) IGT Devices Undivided · (AO0) IGT Devices Intracardiac · AORTIX SYSTEM · AVVIGO Guidance System · Absorb · Absorb GT1 · Alto Abdominal Stent Graft System · Amplia MRI · Artis pheno · Asahi Fielder coronary guide wire · Azurion 7 M20 · Barostim Neo System · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CLINICAL TRIAL PRODUCT · COREVALVE EVOLUT R · CVI Systems · CardiAMP · Cardiovascular- Research only · Claria MRI · Comet · Connect HF · CoreValve Evolut · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · EKOSONIC · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · FFRct · FLOWTRIEVER CATHETER · FlowMet · GENERAL BALLOONS · GENERAL METALLIC STENTS · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL - THERAPIES · GORE CARDIOFORM Septal Occluder · HawkOne · IGT Equip Undiv · IN.PACT Admiral · Impella · JARDIANCE · KONECT RESILIA · LEQVIO · LIMFLOW SYSTEM · LUTONIX · LifeVest · MITRACLIP · Mitra Clip system · ONYX FRONTIER · OPSUMIT · OPTICROSS · Optis Coronary Imaging System · PULSESELECT · Peripheral Orbital Atherectomy System · RADIAL 360 · RESOLUTE ONYX · Repatha · Resolute · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · Serrantor · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · SurVeil · TEG6S HEMOSTASIS SYSTEM · Tendyne Mitral Valve System · TherOx DS2 Console · UPTRAVI · VYNDAQEL · Vascepa · Visi-Pro · WATCHMAN · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for cardiovascular disease in MA.

Looking for a cardiovascular disease specialist in Burlington?
Compare cardiologists in the Burlington area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Waxman is an interventional & cardiac specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 4% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Waxman experienced with transcatheter aortic valve replacement via femoral artery?
Based on Medicare claims data, Dr. Waxman performed 16 transcatheter aortic valve replacement via femoral artery services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waxman receive payments from pharmaceutical companies?
Yes. Dr. Waxman received a total of $156,393 from 40 companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waxman's costs compare to other cardiologists in Burlington?
Dr. Waxman's average Medicare payment per service is $342. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waxman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →